Back to Search
Start Over
Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma
- Source :
- Bone Marrow Transplantation, Bone Marrow Transplantation, 2020, 55 (12), pp.2335-2338. ⟨10.1038/s41409-020-0946-x⟩, Bone marrow transplantation, 2335-2338. Nature Publishing Group, ISSUE=12;STARTPAGE=2335;ENDPAGE=2338;ISSN=0268-3369;TITLE=Bone marrow transplantation, Bone Marrow Transplantation, Nature Publishing Group, 2020, 55 (12), pp.2335-2338. ⟨10.1038/s41409-020-0946-x⟩, Bone Marrow Transplantation, 55(12), 2335-2338. Nature Publishing Group
- Publication Year :
- 2020
-
Abstract
- International audience
- Subjects :
- Oncology
medicine.medical_specialty
Follicular lymphoma
MEDLINE
Medizin
INHIBITION
Cancer immunotherapy
03 medical and health sciences
0302 clinical medicine
Targeted therapies
Clinical trials
Internal medicine
Correspondence
medicine
Humans
In patient
RITUXIMAB
Lymphoma, Follicular
ComputingMilieux_MISCELLANEOUS
Quinazolinones
Transplantation
OUTCOMES
business.industry
Hematopoietic Stem Cell Transplantation
Correction
Hematology
medicine.disease
3. Good health
Purines
030220 oncology & carcinogenesis
[SDV.IMM]Life Sciences [q-bio]/Immunology
TRIAL
Stem cell
business
Idelalisib
030215 immunology
Subjects
Details
- Language :
- English
- ISSN :
- 02683369
- Issue :
- 12
- Database :
- OpenAIRE
- Journal :
- Bone marrow transplantation
- Accession number :
- edsair.doi.dedup.....4d5a287173e19f5444a78830f4dc41d1
- Full Text :
- https://doi.org/10.1038/s41409-020-0946-x